Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Bitcoin Price Prediction: BTC Slips Below $81K as AlphaPepe’s $3M Presale Builds Toward The Next 50x Crypto
-
Remittix, Polkadot and Litecoin: Best Crypto to Buy as DOT Nears $1.10 and LTC Celebrates 15 Years?
-
Inside Cathay Express Transportation: The 24/7 Operations Connecting New Yorkers to School, Healthcare, and Everyday Life
-
International Seaways Expands VLCC Fleet Through Strategic Combination with Bruton Limited.
-
Canton Fair Opens 140th Session, Celebrates Its 70 Years with the Documentary "Chasing the Light"
-
Three Orelabrutinib Studies Presented in Oral Sessions at the 88th Annual Meeting of the Japanese Society of Hematology
-
Electrolux Food Foundation celebrates its 10th anniversary
-
Lawmakers Demand Menhaden Cuts Before Chesapeake Bay Science Is Complete, Ignoring Already Struggling Workers
-
Solana Price Prediction: Alpenglow Is Scheduled for October 21 as Remittix Prepares Its November 24 Token Debut
-
Bekaert: Update on the Share Buyback Program and the Liquidity Agreement
-
Bitcoin Price Today: BTC Trades Near $81,500 After Strategy’s Latest Buy as Remittix’s November Countdown Continues
-
Best Crypto Presale: AlphaPepe Combines Instant Token Delivery With a 100x Entry Before Its First Exchange Trade
-
Huawei Commits to Advancing an Intelligent, Green Europe with Customers and Partners
-
Horizon3 and Pax8 Expand Partnership to Bring Autonomous Security Testing to MSPs Across Europe
-
NUU Launches the N10 Plus, an Unlocked Android 16 Affordable Smartphone: All the Phone You Need. Beautifully Simple.
-
Orosur Mining Inc. - Notice of Annual and Special Meeting
-
Advantech Partners with DEKRA, Signing MOU to Strengthen Global Industrial Cybersecurity Compliance in Response to EU CRA
-
NIPPON EXPRESS HOLDINGS Acquires All Shares of Metro Supply Chain Group
-
Norsk Hydro: Reminder - Invitation to Hydro's third quarter results 2026
-
Microbiotica Raises £36 Million ($48 Million) in Series C Financing to Advance Pipeline into Phase 2 Clinical Development
-
Director/PDMR Shareholding
-
IBA and Framatome join forces to industrialize Astatine-211 production for cancer therapies
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 16
-
Norsk Hydro: Reminder - Invitation to Hydro's third quarter results 2026
-
Latest Crypto News: Puffer Soars, but Could AlphaPepe’s Ex-Shibarium Developer Build the Next SHIB Millionaire Maker?
-
LeadSnap Launches MCP Server, Opening the Door to AI-Powered Local SEO, Reporting and Prospecting
-
EX9 to Headline New Vehicle Debuts as EXEED Reveals Design Language Launch Highlights at the 2026 International User Summit
-
Reverse Speech Founder David John Oates Marks Over 40 Years of Controversial Research and a Literary Career Spanning Nearly 30 Books
-
Cardano Price Prediction: ADA Processes 1.78M Transactions in Five Days as Remittix Prepares Its First Market Cycle
-
Cryptocurrency News: NEAR Debates Lower Token Issuance as Remittix’s Planned Final Tier Puts Its $0.28 Entry in Focus
-
Allegiance Commences Initial Field Program at 100%-Owned Golden Scheelite Tungsten Project in Nevada
-
AB Tewox publishes its factsheet for Q3 2026
-
FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
-
Lavazza Expands to Five Stores in Hong Kong and Launches Signature Buffalo Milk Latte
-
Start of Day Message
-
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
-
Choosing a Polyurethane Dewatering Panel for Washed Sand and Aggregate
-
Show Flooring Helps Chicago Homeowners With Flood-Damaged Flooring Replacement Following Severe Storms
-
Chinese Garment Printing Line Manufacturers: How to Compare Complete DTF DTG Screen and Sublimation Systems
-
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer
-
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer
-
Prospera Energy Restarts Five Additional Luseland Wells at $6,400 per Flowing Barrel; First Ten Reactivations Return 1.92x Capital
-
Kylie Minogue, Jonathan Groff, and Catherine Tate Join Cynthia Erivo in Bad Fairies
-
HiTHIUM Surpasses 200GWh in Shipments, Advancing Global Long-Duration Energy Storage with Full-Chain Integration
-
University of Phoenix leaders to share expertise on learner mobility and credential innovation at Convergence 2026
-
How Fast Will Charging Be in the Future? 2026 Chery International User Summit to Unlock Next-Gen Smart Energy Experience
-
Chinese Publishing at the 2026 Frankfurt Book Fair: Bringing Chinese Stories to the World
-
From Protecting Ecosystems to Supporting Public Safety: OMODA & JAECOO Creates Local Value Through Global Community Initiatives
